Nanosphere Files for IPO; Hopes to Raise at Least $90M | GenomeWeb
NEW YORK (GenomeWeb News) - Molecular diagnostics developer Nanosphere yesterday filed a prospectus for its initial public offering with the US Securities and Exchange Commission.
 
The NorthBrook, Ill.-based company plans to trade on the Nasdaq Global Market under the symbol "NSPH."
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.